Omics technologies, including genomics, transcriptomics, proteomics, and metabolomics, have become powerful tools in plant biotechnology, providing a comprehensive understanding of plant biology at multiple levels. These technologies allow scientists to study the entire genetic makeup, gene expression patterns, protein profiles, and metabolic processes of plants. By applying omics approaches, researchers can identify key genes and pathways responsible for important traits such as drought resistance, pest resistance, and improved nutritional content. Additionally, omics data can accelerate the development of genetically modified plants and aid in marker-assisted breeding. The integration of omics technologies with other biotechnological tools offers the potential to create crops with enhanced traits, optimized for productivity and sustainability. Furthermore, omics approaches are helping to uncover plant responses to environmental stresses, enabling the development of crops better adapted to changing climate conditions and ensuring long-term food security. Omics in plant biotechnology is also paving the way for advancements in precision agriculture by providing insights into the molecular mechanisms underlying plant-environment interactions.
Title : Biovalorization of overripe banana (Musa spp.) extract as a functional ingredient for glycemic regulation in diabesity management
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title :
Valasia Iakovoglou, UNESCO chair Con-E-Ect, International Hellenic University, Greece
Title : The antimicrobial activity of six Ocimum species against human microbial pathogens
Srinivasa Rao Mentreddy, Alabama A&M University, United States
Title : Effect of climate and weather on plant biology and biotechnology
Vijayan Gurumurthy Iyer, Techno-Economic-Environmental Study and Check Consultancy Services, India
Title : Cambial rearrangement in cycads: First evidence from a basal seed plant lineage
Anna Ponce, Bethune-Cookman University, United States
Title : Utilizing plant derived extracellular vesicles for drug delivery and therapeutic development
Hillary Jean Pierre, Department of Pharmaceutics, United States